Can MRI predict heart failure outcomes? new study investigates
NCT ID NCT03999138
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether MRI can accurately measure fluid buildup in the lungs of people hospitalized for acute heart failure. Researchers will track 300 patients from admission to discharge to see how lung water changes with treatment and whether these measurements can predict who is at higher risk of returning to the hospital or dying. The goal is to improve monitoring and risk assessment for heart failure patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2019
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients admitted to hospital with a diagnosis of acute heart failure
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18 years of age or older and willing/able to provide informed consent * patients being treated for acute heart failure (including those patients with both reduced and preserved ejection fraction) * patients receiving medical therapy for pulmonary edema by current standard of care (including oral or IV diuretics) * patients identified within 48 hours of initiation of medical therapy for pulmonary edema, defined as the time of first diuretic (IV or PO) or escalation of existing diuretic therapy administered within the ED or hospital Exclusion Criteria: * contraindication to MRI * patient too critically ill/unstable as per the clinical care team for transport to MRI scanner within the required scanning window * moderate to severe dementia
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Alberta
ACTIVE_NOT_RECRUITINGEdmonton, Alberta, Canada
-
University of Ottawa Heart Institute
RECRUITINGOttawa, Ontario, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a COPD flare stun the heart? study watches for hidden strain
- Can urine tests guide better diuretic dosing in heart failure?
- AI plus ultrasound could catch heart and lung decline before it turns critical
- Can a second diuretic boost recovery from heart failure?
- 21-Protein blood test aims to spot hidden heart failure in the ER
- Hospital heart pill may prevent repeat crises